Document Detail


The diagnostic accuracy of attention-deficit/hyperactivity disorder in adults with substance use disorders.
MedLine Citation:
PMID:  22449768     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
PURPOSE OF REVIEW: Adult attention deficit/hyperactivity disorder (ADHD) is a common comorbid condition to substance use disorder (SUD) and is associated with worse prognosis and quality of life. This review summarizes recent work assessing ADHD diagnosis reliability in SUD patients and provides arguments to enhance the accuracy of detecting this disorder. RECENT FINDINGS: Adequate diagnosis of ADHD in SUD patients is challenged by phenomenological aspects of addiction and frequently associated other psychiatric disorders that overlap with key symptoms of ADHD. A detailed comprehensive search for child and adult symptoms including the temporal relationship of ADHD, substance use and other psychiatric disorders should maximize the validity and the reliability of adult ADHD diagnosis in this population. Further, a follow-up evaluation of ADHD symptoms during treatment of SUD may reduce the likelihood of misdiagnosis. SUMMARY: Considering the high rate of ADHD comorbidity among SUD patients, it is crucial to promote a systematic diagnostic approach to this disorder in specialized addiction treatment settings. However, overlapping symptoms between disorders frequently challenge the accuracy of adult ADHD diagnosis. Areas in need of further investigations include the development of valid screening procedures, associated neuropsychological factors and effective treatment strategies for these populations.
Authors:
Melina Fatseas; Romain Debrabant; Marc Auriacombe
Related Documents :
23606908 - Impulse control disorders in parkinson's disease: background and update on prevention a...
22854508 - Treatment of antineutrophil cytoplasmic antibody-associated vasculitis.
23559798 - Clinical efficacy of shiva guggulu and simhanada guggulu in amavata (rheumatoid arthrit...
24559868 - The foot and ankle examination.
1623338 - Psychopharmacological treatment of panic disorder.
11225508 - Comorbidity in generalized anxiety disorder.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-3-23
Journal Detail:
Title:  Current opinion in psychiatry     Volume:  -     ISSN:  1473-6578     ISO Abbreviation:  -     Publication Date:  2012 Mar 
Date Detail:
Created Date:  2012-3-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8809880     Medline TA:  Curr Opin Psychiatry     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
aLaboratoire de Psychiatrie/CNRS USR 3413 (Sanpsy), Université Bordeaux Segalen bDépartement d'Addictologie, CH Charles Perrens and CHU de Bordeaux, Bordeaux, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Psychiatric comorbidity in injecting drug users in Asia and Africa.
Next Document:  Recent progress in the understanding and treatment of nonepileptic seizures.